Androgen Excess as a Mechanism for Adipogenic Dysfunction in Polycystic Ovarian Syndrome (PCOS) Women
Women with and Without Polycystic Ovarian Syndrome (PCOS) May Be Eligible to Participate in a Research Study To Learn More About How Body Fat Affects Women’s Health. Dr. Daniel Dumesic and his research team from the UCLA Department of Obstetrics and Gynecology are conducting a study to learn more about endocrine and metabolic conditions in women. The team is recruiting the following three groups of women for participation:
Participants in all groups must meet the following criteria:
If you've answered yes to all of the questions, please email us at Health4Women@ucla.edu or call us at 310-794-2514.
All participants in the study will receive extensive free medical testing including:
After completing the above tests, women with regular menstrual cycles (controls) will conclude their participation in this study. Women with PCOS or irregular menstrual periods will be randomized to take the drug Flutamide or a placebo (sugar pill) every day for 6 consecutive 28 day cycles and then the tests and procedures listed above will be repeated. Flutamide is a drug that temporarily blocks the action of male hormones in women.
Eligible women may receive up to $200 if they are in the control group and $605 if they are in either of the other two groups. Parking vouchers will be provided. UCLA Protocol ID: IRB# 12-001780
Please call (310) 794-2514 to learn more. In order to protect your privacy, please do not include any personal health information if you choose to e-mail us at Health4Women@mednet.ucla.edu.
For millions of women with the condition known as Uterine Fibroids, symptoms like heavy periods, bloating, and pelvic pain or pressure routinely interfere with everyday life.
Dr. Steve Yu from the Department of Obstetrics & Gynecology is now enrolling participants for a study comparing approved uterine-sparing fibroid treatments. Women 18 or older with untreated fibroids who wish to receive treatment and avoid hysterectomy may be eligible to receive treatment through the TRUST (Treatment Results of Uterine Sparing Technologies) USA study. Information on the study can be found at www.ClinicalTrials.gov (search identifier: NCT02163525). For a medical consultation, please call (310) 451-8144.
To find out if you are eligible to participate in the study, contact:
Anna Amamchyan @ (310)-825-5255 or
Ria Jain @ (310)-206-6049
or e-mail us: UCLAOBGYNresearch@mednet.ucla.edu
Researchers from the University of California, Los Angeles (UCLA) are enrolling women in COMPARE, a nationwide study to help women and doctors better understand the effects of different treatments options for fibroids including symptom relief, fertility and pregnancy, and the need for additional fibroid treatment. You may qualify for the study if:
If you qualify for the study you may:
You will be modestly compensated for your time.
This study is being conducted by Dr. Ram Parvataneni, and Dr. Erica Oberman, in the Department of Obstetrics and Gynecology. If you are interested please contact the Study Coordinator at (310) 206-6049.
Objective of the research project: The purpose of this study is to learn how environmental pollution may affect the function of the placenta through the use of MRI imaging.
You will be compensated $75 per completed MRI, a total of $150 in a form of a Target gift card. You will also receive 3D MRI images of your baby in a digital format.
For information on inclusion and exclusion criteria, please email TChanlaw@mednet.ucla.edu or call 310-206-5435. A member from the study team will contact you as soon as possible.
More about this clinical trial >
If you are female between the ages of 18 to 55 and have been diagnosed with vestibulodynia or vulvodynia OR are experiencing chronic pain at the opening of the vagina or at the area surrounding the opening, with or without intercourse, we would like you to participate in a research study. This study is conducted by Dr. Jennifer Labus at the UCLA Oppenheimer Center for Neurobiology of Stress (http://uclacns.org/) and Dr. Andrea Rapkin at the Department of Obstetrics and Gynecology.
Earn up to $130 for your participation
The purpose of this research is to help understand the physiology and genetic makeup of this chronic pain condition. Participation involves 2 visits (1 screening, 1 MRI scan) over approximately 1-3 weeks. You must be right-handed and not pregnant. For further details, please e-mail firstname.lastname@example.org or call 310-825-5255.
Affiliated: Gynecology | Women’s Health Clinical Research
The UCLA Infertility Program is conducting a study to learn more about the relationship between body fat and infertility. Women under the age of 42 who are scheduled to undergo In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) may be eligible to participate provided they have not had ovarian surgery, ovarian endometriomas, or taken medications known to affect metabolic function over the preceding 2 months. Women can choose to participate in either of the following 2 options:
Women participating in option #1 will receive $100.
Participants and/or their insurance companies will be responsible for all costs related to the IVF and ICSI procedures. If you wish to learn more about this study, please email email@example.com or call 310-825-0580. IRB#: 12-000402
Affiliated: Fertility Doctors | What is Infertility?
For more information about specific trials at UCLA, please call Sonali S. Namiranian, BS, MBA-BT, CCRP at (310) 794-9095 or e-mail her at firstname.lastname@example.org
At UCLA OB/GYN, Our Mission is
The Women’s Healthcare Research Program at UCLA provides women with PCOS, and other androgen-related diseases, the highest level of care and quality of life. Learn about our research >
Our fertility services are comprehensive, compassionate and individualized, based upon mutual respect and the needs and preferences of the couple. Meet our doctors >
For assistance in determining which doctors may have expertise to help you, please call the OB/GYN Appointment phone number:
(310) 794-7274 Request an appointment >